Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Research Shows CT Scanner’s Benefits Offset Cancer Risks in Young Adults

By HospiMedica International staff writers
Posted on 20 Feb 2013
The underlying medical conditions facing young adults who undergo computed tomography (CT) scanning are representative of an appreciably greater health risk than that of radiation-induced cancer from CT, according to new findings.

The study’s findings were published online before print on February 5, 2013, in the journal Radiology. More...
CT utilization has grown approximately 10% per year over the last 15 years in the United States, raising worries of an increase in radiation-induced cancers. However, discussions of radiation-induced cancer risk often fail to take into account the condition of the patients being imaged, according to Susanna Lee, MD, PhD, chief of women’s imaging at Massachusetts General Hospital (Boston, MA, USA) and assistant professor of radiology at Harvard Medical School (Boston, MA, USA). “The impetus for our study was the concern that the lay press often focuses on potential harm caused to patients by CT imaging,” Dr. Lee said. “Lacking in this discussion is a sense of how sick these patients already are.”

To better determine the pros and cons of CT in young adults, the researchers, led by Dr. Lee and researcher Robert L. Zondervan, MS, studied imaging records of patients 18 to 35 years old who underwent chest or abdominopelvic CT scans between 2003 and 2007 at one of three university-affiliated hospitals in Boston. Children and young adults are more susceptible to ionizing radiation and more likely to live for the approximately 10 to 20 years considered necessary to develop a radiation-induced malignancy.

The researchers had access to records from 22,000 patients, including 16,851 chest and 24,112 abdominopelvic CT scans. During the average 5.5-year follow-up period, 7.1% of young adults who underwent chest CT scanning, and 3.9% of those who had abdominopelvic CT died—statistics that were much greater than the 0.1% long-term risk of death from radiation-induced cancer predicted by statistical models in both groups. “It was a bit surprising to see how high the five-year mortality rate was in this group,” Dr. Lee said. “To put it in context, the average young adult has only a 1% chance of dying in the next five years.”

The most typical reasons for exam were cancer and trauma for chest CT, and abdominal pain and trauma, and cancer for abdominopelvic CT scanning. Whereas many of the patients who underwent CT were cancer patients with a poor prognosis, Dr. Lee noted that the key differences in risk were evident in the other groups who had CT imaging, such as those suffering from trauma, abdominal pain, and difficulty breathing. “When we subtracted out cancer patients from the data set, the risk of death in the study group ranged from 2.5%–5%—still well above the risk in the general population,” she said.

Dr. Lee and colleagues also discovered that the patients who were scanned only one or two times represented the overwhelming percentage of scans. “This finding shows that radiation reduction efforts should also focus on patients who are very rarely scanned, and not just those who are scanned repeatedly,” Dr. Lee said.

Dr. Lee noted that the study group was imaged between 2003 and 2007, before radiation dose awareness and reduction programs such as Image Wisely and Image Gently took effect. She reported that the risk of radiation-induced cancer from CT in all probability would be lower today, making the difference in mortality even more pronounced. “We’re not saying be complacent about the radiation risk from CT,” Dr. Lee added. “But these people being imaged might have been in a motor vehicle accident, or have a perforated appendix or life-threatening cancer, and we’re trying to gain information from scans that can help them. That’s the part that gets lost in the debate.”

Related Links:

Harvard Medical School




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.